aluates Reports

$ 0.0

Automative

Global Acinetobacter Infections Treatment Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-L9

China Acinetobacter Infections Treatment Market Report Forecast 2021 2027

BUY CHAPTERS

Global Acinetobacter Infections Treatment Market Research Report 2024

Code: QYRE-Auto-L9

Report

January 2024

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen Inc

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

Acinetobacter Infections Treatment Market

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

The global Acinetobacter Infections Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.

This report aims to provide a comprehensive presentation of the global market for Acinetobacter Infections Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acinetobacter Infections Treatment.

Report Scope

The Acinetobacter Infections Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acinetobacter Infections Treatment market comprehensively. Regional market sizes, concerning products by Type, by Pipeline, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acinetobacter Infections Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Pipeline, and by regions.

Market Segmentation

Scope of Acinetobacter Infections Treatment Market Report

Report Metric	Details
Report Name	Acinetobacter Infections Treatment Market
Segment by Type	Sulbactam Carbapenems Aminoglycosides Polymyxins Tetracyclines Others
Segment by Pipeline	ETX2514 Nacubactam RG6080 Arenicin VXD-001 Small Molecule Antibiotic AR-401 mAB LCB01-0371 (PO) GN-4474 Antibacterial Antibody Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife PHARMA, Shionogi, Techulon, Tetraphase Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Pipeline, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acinetobacter Infections Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Pipeline, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the market share of major companies in Acinetobacter Infections Treatment Market?

Ans: Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.

Who are the main players in the Acinetobacter Infections Treatment Market report?

Ans: The main players in the Acinetobacter Infections Treatment Market are Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife PHARMA, Shionogi, Techulon, Tetraphase Pharmaceuticals

What are the Type segmentation covered in the Acinetobacter Infections Treatment Market report?

Ans: The Types covered in the Acinetobacter Infections Treatment Market report are Sulbactam, Carbapenems, Aminoglycosides, Polymyxins, Tetracyclines, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Sulbactam

1.2.3 Carbapenems

1.2.4 Aminoglycosides

1.2.5 Polymyxins

1.2.6 Tetracyclines

1.2.7 Others

1.3 Market by Pipeline

1.3.1 Global Acinetobacter Infections Treatment Market Growth by Pipeline: 2019 VS 2023 VS 2030

1.3.2 ETX2514

1.3.3 Nacubactam RG6080

1.3.4 Arenicin

1.3.5 VXD-001

1.3.6 Small Molecule Antibiotic

1.3.7 AR-401 mAB

1.3.8 LCB01-0371 (PO)

1.3.9 GN-4474

1.3.10 Antibacterial Antibody

1.3.11 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acinetobacter Infections Treatment Market Perspective (2019-2030)

2.2 Acinetobacter Infections Treatment Growth Trends by Region

2.2.1 Global Acinetobacter Infections Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Acinetobacter Infections Treatment Historic Market Size by Region (2019-2024)

2.2.3 Acinetobacter Infections Treatment Forecasted Market Size by Region (2025-2030)

2.3 Acinetobacter Infections Treatment Market Dynamics

2.3.1 Acinetobacter Infections Treatment Industry Trends

2.3.2 Acinetobacter Infections Treatment Market Drivers

2.3.3 Acinetobacter Infections Treatment Market Challenges

2.3.4 Acinetobacter Infections Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acinetobacter Infections Treatment Players by Revenue

3.1.1 Global Top Acinetobacter Infections Treatment Players by Revenue (2019-2024)

3.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Acinetobacter Infections Treatment Revenue

3.4 Global Acinetobacter Infections Treatment Market Concentration Ratio

3.4.1 Global Acinetobacter Infections Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acinetobacter Infections Treatment Revenue in 2023

3.5 Acinetobacter Infections Treatment Key Players Head office and Area Served

3.6 Key Players Acinetobacter Infections Treatment Product Solution and Service

3.7 Date of Enter into Acinetobacter Infections Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Acinetobacter Infections Treatment Breakdown Data by Type

4.1 Global Acinetobacter Infections Treatment Historic Market Size by Type (2019-2024)

4.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2025-2030)

5 Acinetobacter Infections Treatment Breakdown Data by Pipeline

5.1 Global Acinetobacter Infections Treatment Historic Market Size by Pipeline (2019-2024)

5.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2025-2030)

6 North America

6.1 North America Acinetobacter Infections Treatment Market Size (2019-2030)

6.2 North America Acinetobacter Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Acinetobacter Infections Treatment Market Size by Country (2019-2024)

6.4 North America Acinetobacter Infections Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acinetobacter Infections Treatment Market Size (2019-2030)

7.2 Europe Acinetobacter Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Acinetobacter Infections Treatment Market Size by Country (2019-2024)

7.4 Europe Acinetobacter Infections Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acinetobacter Infections Treatment Market Size (2019-2030)

8.2 Asia-Pacific Acinetobacter Infections Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acinetobacter Infections Treatment Market Size (2019-2030)

9.2 Latin America Acinetobacter Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Acinetobacter Infections Treatment Market Size by Country (2019-2024)

9.4 Latin America Acinetobacter Infections Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acinetobacter Infections Treatment Market Size (2019-2030)

10.2 Middle East & Africa Acinetobacter Infections Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Entasis Therapeutics

11.1.1 Entasis Therapeutics Company Detail

11.1.2 Entasis Therapeutics Business Overview

11.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Introduction

11.1.4 Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.1.5 Entasis Therapeutics Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Acinetobacter Infections Treatment Introduction

11.2.4 Roche Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.2.5 Roche Recent Development

11.3 Adenium Biotech

11.3.1 Adenium Biotech Company Detail

11.3.2 Adenium Biotech Business Overview

11.3.3 Adenium Biotech Acinetobacter Infections Treatment Introduction

11.3.4 Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.3.5 Adenium Biotech Recent Development

11.4 Vaxdyn

11.4.1 Vaxdyn Company Detail

11.4.2 Vaxdyn Business Overview

11.4.3 Vaxdyn Acinetobacter Infections Treatment Introduction

11.4.4 Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.4.5 Vaxdyn Recent Development

11.5 Hsiri Therapeutics

11.5.1 Hsiri Therapeutics Company Detail

11.5.2 Hsiri Therapeutics Business Overview

11.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Introduction

11.5.4 Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.5.5 Hsiri Therapeutics Recent Development

11.6 Aridis Pharmaceuticals

11.6.1 Aridis Pharmaceuticals Company Detail

11.6.2 Aridis Pharmaceuticals Business Overview

11.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Introduction

11.6.4 Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.6.5 Aridis Pharmaceuticals Recent Development

11.7 LegoChem Biosciences

11.7.1 LegoChem Biosciences Company Detail

11.7.2 LegoChem Biosciences Business Overview

11.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Introduction

11.7.4 LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.7.5 LegoChem Biosciences Recent Development

11.8 Atterx Biotherapeutics

11.8.1 Atterx Biotherapeutics Company Detail

11.8.2 Atterx Biotherapeutics Business Overview

11.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Introduction

11.8.4 Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.8.5 Atterx Biotherapeutics Recent Development

11.9 Achaogen

11.9.1 Achaogen Company Detail

11.9.2 Achaogen Business Overview

11.9.3 Achaogen Acinetobacter Infections Treatment Introduction

11.9.4 Achaogen Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.9.5 Achaogen Recent Development

11.10 Peptilogics

11.10.1 Peptilogics Company Detail

11.10.2 Peptilogics Business Overview

11.10.3 Peptilogics Acinetobacter Infections Treatment Introduction

11.10.4 Peptilogics Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.10.5 Peptilogics Recent Development

11.11 Sealife PHARMA

11.11.1 Sealife PHARMA Company Detail

11.11.2 Sealife PHARMA Business Overview

11.11.3 Sealife PHARMA Acinetobacter Infections Treatment Introduction

11.11.4 Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.11.5 Sealife PHARMA Recent Development

11.12 Shionogi

11.12.1 Shionogi Company Detail

11.12.2 Shionogi Business Overview

11.12.3 Shionogi Acinetobacter Infections Treatment Introduction

11.12.4 Shionogi Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.12.5 Shionogi Recent Development

11.13 Techulon

11.13.1 Techulon Company Detail

11.13.2 Techulon Business Overview

11.13.3 Techulon Acinetobacter Infections Treatment Introduction

11.13.4 Techulon Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.13.5 Techulon Recent Development

11.14 Tetraphase Pharmaceuticals

11.14.1 Tetraphase Pharmaceuticals Company Detail

11.14.2 Tetraphase Pharmaceuticals Business Overview

11.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Introduction

11.14.4 Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2019-2024)

11.14.5 Tetraphase Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen Inc

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

List of Tables

Table 1. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Sulbactam

Table 3. Key Players of Carbapenems

Table 4. Key Players of Aminoglycosides

Table 5. Key Players of Polymyxins

Table 6. Key Players of Tetracyclines

Table 7. Key Players of Others

Table 8. Global Acinetobacter Infections Treatment Market Size Growth by Pipeline (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Acinetobacter Infections Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Acinetobacter Infections Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Acinetobacter Infections Treatment Market Share by Region (2019-2024)

Table 12. Global Acinetobacter Infections Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Acinetobacter Infections Treatment Market Share by Region (2025-2030)

Table 14. Acinetobacter Infections Treatment Market Trends

Table 15. Acinetobacter Infections Treatment Market Drivers

Table 16. Acinetobacter Infections Treatment Market Challenges

Table 17. Acinetobacter Infections Treatment Market Restraints

Table 18. Global Acinetobacter Infections Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Acinetobacter Infections Treatment Market Share by Players (2019-2024)

Table 20. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acinetobacter Infections Treatment as of 2023)

Table 21. Ranking of Global Top Acinetobacter Infections Treatment Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Acinetobacter Infections Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Acinetobacter Infections Treatment Product Solution and Service

Table 25. Date of Enter into Acinetobacter Infections Treatment Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Acinetobacter Infections Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2019-2024)

Table 29. Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2025-2030)

Table 31. Global Acinetobacter Infections Treatment Market Size by Pipeline (2019-2024) & (US$ Million)

Table 32. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2019-2024)

Table 33. Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2025-2030) & (US$ Million)

Table 34. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2025-2030)

Table 35. North America Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Acinetobacter Infections Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Acinetobacter Infections Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Acinetobacter Infections Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Acinetobacter Infections Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Acinetobacter Infections Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Acinetobacter Infections Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Acinetobacter Infections Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 50. Entasis Therapeutics Company Detail

Table 51. Entasis Therapeutics Business Overview

Table 52. Entasis Therapeutics Acinetobacter Infections Treatment Product

Table 53. Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 54. Entasis Therapeutics Recent Development

Table 55. Roche Company Detail

Table 56. Roche Business Overview

Table 57. Roche Acinetobacter Infections Treatment Product

Table 58. Roche Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 59. Roche Recent Development

Table 60. Adenium Biotech Company Detail

Table 61. Adenium Biotech Business Overview

Table 62. Adenium Biotech Acinetobacter Infections Treatment Product

Table 63. Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 64. Adenium Biotech Recent Development

Table 65. Vaxdyn Company Detail

Table 66. Vaxdyn Business Overview

Table 67. Vaxdyn Acinetobacter Infections Treatment Product

Table 68. Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 69. Vaxdyn Recent Development

Table 70. Hsiri Therapeutics Company Detail

Table 71. Hsiri Therapeutics Business Overview

Table 72. Hsiri Therapeutics Acinetobacter Infections Treatment Product

Table 73. Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 74. Hsiri Therapeutics Recent Development

Table 75. Aridis Pharmaceuticals Company Detail

Table 76. Aridis Pharmaceuticals Business Overview

Table 77. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product

Table 78. Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 79. Aridis Pharmaceuticals Recent Development

Table 80. LegoChem Biosciences Company Detail

Table 81. LegoChem Biosciences Business Overview

Table 82. LegoChem Biosciences Acinetobacter Infections Treatment Product

Table 83. LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 84. LegoChem Biosciences Recent Development

Table 85. Atterx Biotherapeutics Company Detail

Table 86. Atterx Biotherapeutics Business Overview

Table 87. Atterx Biotherapeutics Acinetobacter Infections Treatment Product

Table 88. Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 89. Atterx Biotherapeutics Recent Development

Table 90. Achaogen Company Detail

Table 91. Achaogen Business Overview

Table 92. Achaogen Acinetobacter Infections Treatment Product

Table 93. Achaogen Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 94. Achaogen Recent Development

Table 95. Peptilogics Company Detail

Table 96. Peptilogics Business Overview

Table 97. Peptilogics Acinetobacter Infections Treatment Product

Table 98. Peptilogics Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 99. Peptilogics Recent Development

Table 100. Sealife PHARMA Company Detail

Table 101. Sealife PHARMA Business Overview

Table 102. Sealife PHARMA Acinetobacter Infections Treatment Product

Table 103. Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 104. Sealife PHARMA Recent Development

Table 105. Shionogi Company Detail

Table 106. Shionogi Business Overview

Table 107. Shionogi Acinetobacter Infections Treatment Product

Table 108. Shionogi Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 109. Shionogi Recent Development

Table 110. Techulon Company Detail

Table 111. Techulon Business Overview

Table 112. Techulon Acinetobacter Infections Treatment Product

Table 113. Techulon Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 114. Techulon Recent Development

Table 115. Tetraphase Pharmaceuticals Company Detail

Table 116. Tetraphase Pharmaceuticals Business Overview

Table 117. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product

Table 118. Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2019-2024) & (US$ Million)

Table 119. Tetraphase Pharmaceuticals Recent Development

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Acinetobacter Infections Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Acinetobacter Infections Treatment Market Share by Type: 2023 VS 2030

Figure 3. Sulbactam Features

Figure 4. Carbapenems Features

Figure 5. Aminoglycosides Features

Figure 6. Polymyxins Features

Figure 7. Tetracyclines Features

Figure 8. Others Features

Figure 9. Global Acinetobacter Infections Treatment Market Size Comparison by Pipeline (2024-2030) & (US$ Million)

Figure 10. Global Acinetobacter Infections Treatment Market Share by Pipeline: 2023 VS 2030

Figure 11. ETX2514 Case Studies

Figure 12. Nacubactam RG6080 Case Studies

Figure 13. Arenicin Case Studies

Figure 14. VXD-001 Case Studies

Figure 15. Small Molecule Antibiotic Case Studies

Figure 16. AR-401 mAB Case Studies

Figure 17. LCB01-0371 (PO) Case Studies

Figure 18. GN-4474 Case Studies

Figure 19. Antibacterial Antibody Case Studies

Figure 20. Others Case Studies

Figure 21. Acinetobacter Infections Treatment Report Years Considered

Figure 22. Global Acinetobacter Infections Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 23. Global Acinetobacter Infections Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 24. Global Acinetobacter Infections Treatment Market Share by Region: 2023 VS 2030

Figure 25. Global Acinetobacter Infections Treatment Market Share by Players in 2023

Figure 26. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acinetobacter Infections Treatment as of 2023)

Figure 27. The Top 10 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2023

Figure 28. North America Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. North America Acinetobacter Infections Treatment Market Share by Country (2019-2030)

Figure 30. United States Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Canada Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Europe Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Europe Acinetobacter Infections Treatment Market Share by Country (2019-2030)

Figure 34. Germany Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. France Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. U.K. Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Italy Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Russia Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Nordic Countries Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Asia-Pacific Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Asia-Pacific Acinetobacter Infections Treatment Market Share by Region (2019-2030)

Figure 42. China Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Japan Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Latin America Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Latin America Acinetobacter Infections Treatment Market Share by Country (2019-2030)

Figure 50. Mexico Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Brazil Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2019-2030)

Figure 54. Turkey Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Acinetobacter Infections Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Entasis Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 57. Roche Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 58. Adenium Biotech Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 59. Vaxdyn Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 60. Hsiri Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 61. Aridis Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 62. LegoChem Biosciences Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 63. Atterx Biotherapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 64. Achaogen Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 65. Peptilogics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 66. Sealife PHARMA Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 67. Shionogi Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 68. Techulon Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 69. Tetraphase Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions